Our Pipelines

In this section you will find current statistics on our products. Our drug for the treatment of brain and liver cancer has received (*) Orphan Drug Designation from the EMA.

SI-053

(brain tumor)

Discovery and Development
Preclinical Research
Clinical Research
Review
Post-Market Safety Monitor

SA-033

(liver tumor)

Discovery and Development
Preclinical Research
Clinical Research
Review
Post-Market Safety Monitor

SA-083

(lung tumor)

Discovery and Development
Preclinical Research
Clinical Research
Review
Post-Market Safety Monitor
Contact Us